Network origin in Craig C. Talluto first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.
10
| Extinct | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Craig C. Talluto via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Chief Executive Officer Director of Finance/CFO | |
| OKYO PHARMA LIMITED | Biotechnology | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Founder Chief Executive Officer Director of Finance/CFO | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member Founder Director/Board Member Director/Board Member | |
| ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ACCUSTEM SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Director/Board Member Founder | |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Pharmaceuticals: Major | Director/Board Member President | |
| TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer | |
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Arna Therapeutics Ltd. is a British biotechnology company that focuses on research and experimental development. The private company was founded by Gabriele Marco Antonio Cerrone. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Medical Specialties | Director/Board Member Director/Board Member | |
Secure Voice Communications, Inc.
 Secure Voice Communications, Inc. Internet Software/ServicesTechnology Services Part of Breitling Energy Corp., Secure Voice Communications, Inc. develops VoIP technologies. The company is based in Plant City, FL. James Leonard Ivins has been the CEO of the company since 2007. Secure Voice Communications was acquired by Edgeline Holdings, Inc. from eLinear, Inc. on July 25, 2007 for $3,239.92 million. | Internet Software/Services | Chief Tech/Sci/R&D Officer | |
Gensignia IP Ltd.
 Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Gensignia IP Ltd. is a professional, scientific, and British technical services company. Part of Gensignia Life Sciences, Inc., the company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Value Relations GmbH | Corporate Officer/Principal | ||
Sinapis Pharma, Inc.
 Sinapis Pharma, Inc. BiotechnologyHealth Technology Sinapis Pharma, Inc. provides biotechnology services. It develops methamphetamine, a low-dose intravenous infusion. The company was founded by Howard C. Chandler and Peter Von Doersten in 2009 and is headquartered in Jacksonville, FL. | Biotechnology | Chief Executive Officer | |
Interactive Therapeutics, Inc.
 Interactive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Interactive Therapeutics, Inc. develops products to treat cancer, infectious diseases and other medical conditions associated with compromised immune systems. The company is headquartered in Houston, TX. | Pharmaceuticals: Major | President | |
| University of Wisconsin | College/University | Doctorate Degree | |
| VIRPAX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Oxford | College/University | Corporate Officer/Principal | |
| Synergy DE | Chairman | ||
| University of Missouri-St. Louis | College/University | Undergraduate Degree | |
| MONSANTO | Wholesale Distributors | Chief Tech/Sci/R&D Officer | |
| G.D. Searle LLC | Corporate Officer/Principal | ||
| IMMURON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
| State University of New York at Albany | College/University | Doctorate Degree | |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Biotechnology | Founder | |
| St. Edmunds Retreat, Inc. | Director/Board Member | ||
PDS Operating Corp.
 PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
i3 Global
 i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
i3 Research, Inc.
 i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Midwestern Connecticut Council of Alcoholism, Inc. | Director/Board Member | ||
| Columbia Business School | College/University | Masters Business Admin | |
| Fairfield University | College/University | Undergraduate Degree | |
Environetics, Inc.
 Environetics, Inc. Wholesale DistributorsDistribution Services Part of Alanco Technologies, Inc., Environetics, Inc. is committed to improving water quality through the development of products which help to solve industrial and municipal water and wastewater quality problems. The company is based in Scottsdale, AZ. The company produces tank & clearwell baffles and covers that provide practical solutions for improving water, wastewater, and air quality. Environetics improves waste treatment by offering a quick, efficient, and satisfactory way to upgrade tank based waste treatment operations through the installation of a Director II system. Environetics was acquired by Alanco Technologies, Inc. on January 06, 1995. | Wholesale Distributors | Director of Finance/CFO | |
META Group, Inc.
 META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| CNS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 41 |
| United Kingdom | 5 |
| Bermuda | 3 |
| Canada | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 23 |
| Commercial Services | 11 |
| Consumer Services | 8 |
| Distribution Services | 3 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 59 |
| Corporate Officer/Principal | 18 |
| Chief Tech/Sci/R&D Officer | 18 |
| Chairman | 18 |
| Founder | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Gabriele Cerrone | 22 |
| Stephen K. Carter | 20 |
| Riccardo Dalla-Favera | 18 |
| John Brancaccio | 17 |
| Gary Jacob | 16 |
| Donald Picker | 16 |
| Bernard Denoyer | 11 |
| Robert C. Shepard | 9 |
| Randall K. Johnson | 3 |
| Christoph Bruening | 2 |
- Stock Market
- Insiders
- Craig C. Talluto
- Company connections